Alterations of the cyclin-dependent kinase inhibitor genes CDKN2A, CDKN2B and CDKN2C in atypical and anaplastic meningiomas

被引：0
|
作者：
Boström, J
Meyer-Puttlitz, B
Blaschke, B
Wolter, M
Weber, RG
Lichter, P
Collins, VP
Reifenberger, G
机构：
[1] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany
[2] Univ Bonn, Med Ctr, Dept Neuropathol, D-5300 Bonn, Germany
[3] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany
[4] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
来源：
BRAIN PATHOLOGY | 2000年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [21] Germline Co-deletion of CDKN2A and CDKN2B Genes in Pleomorphic Xanthoastrocytoma: Case Report
    Agiannitopoulos, Konstantinos
    Katseli, Anastasia
    Potska, Kevisa
    Ntogka, Christina
    Tsaousis, Georgios N.
    Tsoulos, Nikolaos
    Kampoli, Katerina
    Ntavatzikos, Anastasios
    Papadopoulou, Eirini
    Nasioulas, George
    Koumarianou, Anna
    IN VIVO, 2024, 38 (04): : 1671 - 1676
  • [22] Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
    Platz, A
    Hansson, J
    ManssonBrahme, E
    Lagerlof, B
    Linder, S
    Lundqvist, E
    Sevigny, P
    Inganas, M
    Ringborg, U
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (10) : 697 - 702
  • [23] Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
    Flores, JF
    Pollock, PM
    Walker, GJ
    Glendening, JM
    Lin, AHT
    Palmer, JM
    Walters, MK
    Hayward, NK
    Fountain, JW
    ONCOGENE, 1997, 15 (24) : 2999 - 3005
  • [24] Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer
    Abou-Zeid, Abla A.
    Azzam, Amal Z.
    Kamel, Nahla A.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2011, 71 (07): : 542 - 547
  • [25] Inactivation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene in squarnous cell carcinoma of the larynx
    Smigiel, R
    Sasiadek, M
    Krecicki, T
    Rarnsey, D
    Jagielski, I
    Blin, N
    MOLECULAR CARCINOGENESIS, 2004, 39 (03) : 147 - 154
  • [26] CDKN2A/CDKN2B as a Hotspot for Acute Lymphoblastic Leukemia Susceptibility in the Spanish Population
    Gutierrez-Camino, A.
    Martin-Guerrero, I.
    Garcia de Andoin, N.
    Navajas, A.
    Sastre, A.
    Carbone Baneres, A.
    Astigarraga, I.
    Garcia-Orad, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S65 - S66
  • [27] Fadraciclib, an oral CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma with CDKN2A and/or CDKN2B genetic alterations
    Piha-Paul, S.
    Garralda, E.
    Vieito, M.
    Oh, D. Y.
    Huang, J.
    Villalona-Calero, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S26
  • [28] Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
    Ashutosh Kumar Arya
    Sanjay Kumar Bhadada
    Priyanka Singh
    Naresh Sachdeva
    Uma Nahar Saikia
    Divya Dahiya
    Arunanshu Behera
    Anil Bhansali
    Sudhaker D. Rao
    Scientific Reports, 7
  • [29] Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
    Arya, Ashutosh Kumar
    Bhadada, Sanjay Kumar
    Singh, Priyanka
    Sachdeva, Naresh
    Saikia, Uma Nahar
    Dahiya, Divya
    Behera, Arunanshu
    Bhansali, Anil
    Rao, Sudhaker D.
    SCIENTIFIC REPORTS, 2017, 7
  • [30] A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare
    Kumar, R
    Smeds, J
    Berggren, P
    Straume, O
    Rozell, BL
    Akslen, LA
    Hemminki, K
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (06) : 388 - 393
12345